Just recently, the FDA changed the warnings on the Ortho Evra birth control patch yet again. This time the agency updated the warnings to include the results of a new study. This new study showed that users of the Ortho Evra patch are twice as likely to develop blood clots known as thromboembolism (VTE). Women between the ages of 15-44 are among those facing the greater risk. The FDA recommends that women using the Ortho Evra patch speak with their physicians about the risks associated with the patch and alternative methods for birth control. To learn more about this subject, view the FDA website below.
Comments are closed.